Chiron Real Estate Inc. (XRN) AI Stock Analysis
XRN AI stock analysis summary
AI ResearchChiron Real Estate Inc. (XRN) is a healthcare facilities REIT with a market capitalization of $439.3M. In FY2025, revenue increased 16.3% to $161.0M, though the company recorded a net income loss of -$5.8M. The stock offers a forward dividend yield of 6.33% paid monthly, while carrying total debt of $636.9M.
- Market cap
- $439.3M
- Revenue (TTM)
- $153.4M
- P/E
- 8.2x fwd 714.3x
- 1Y return
- -1.0% S&P 500 16.8%
- Avg. target
- $38.56 27.1% vs last close
Bull case
- The mean analyst price target of $38.56 points to 27.1% upside potential from the last closing price of $30.34.
- Chiron delivers a forward dividend yield of 6.33% backed by 13 consecutive years of distributions.
- The company's EV to EBITDA multiple of 8.5x is lower than the US-listed Real Estate peer median of 14.7x.
Bear case
- Chiron generated negative free cash flow of -$8.1M in FY2025 as capital expenditures reached $81.7M.
- Cash reserves stood at just $10.7M compared to total debt of $636.9M as of June 30, 2026.
- Long-term shareholder value has lagged broader markets, with 5-year returns of -42.7% and a 5-year dividend growth contraction of 3.8%.
What Chiron Real Estate does
Chiron Real Estate Inc. is an equity real estate investment trust focused on investing in the future of healthcare facilities. Incorporated in Maryland and established in 2011, the company completed its initial public offering in 2016. Chiron operates with 30 employees, striving to deliver value at the intersection of care, capital, and real estate properties. Its healthcare real estate portfolio forms the foundation of its business activities.
Growth and profitability
Revenue expanded at a 5-year CAGR of 11.5% from FY2020 to FY2025. Annual revenue grew from $115.8M in FY2021 to $161.0M in FY2025, marking 16.3% growth in FY2025 following a decline of 1.8% in FY2024. Operating margin reached 30.7% in FY2025, up from 23.6% in FY2024, while gross margin fell to 6.4%. Net income dropped to -$5.8M with EPS of -$0.04 in FY2025, down from $6.6M in FY2024. For the latest quarter ended June 30, 2026, revenue increased 4.8% year-over-year, contributing to trailing twelve months revenue of $153.4M and a profit margin of 37.8%.
Balance sheet and cash flow
As of June 30, 2026, Chiron held $10.7M in cash and short-term investments alongside $636.9M in total debt, resulting in net debt of $626.3M. The company reported shareholders' equity of $656.9M and total assets of $1.37B, translating to a debt-to-equity ratio of 0.97 and a current ratio of 20.79. Operating cash flow totaled $73.6M in FY2025. Cash uses included capital expenditures of $81.7M, dividend distributions of $58.1M, and share buybacks of $6.0M, generating free cash flow of -$8.1M.
Valuation and performance
At $30.34, Chiron trades at a trailing price-to-earnings ratio of 8.2x, below the US-listed Real Estate peer median of 21.6x, but its forward P/E stands at 714.3x versus the peer median of 23.5x. Chiron carries an EV to EBITDA ratio of 8.5x compared to the peer median of 14.7x, and a price-to-sales multiple of 2.9x against 3.7x for peers. Over the past year, Chiron returned -1.0%, underperforming the 16.8% return of the S&P 500, while its 5-year return of -42.7% lagged the S&P 500 gain of 83.0%.
XRN dividend
Chiron pays a monthly dividend with an annualized forward payout of $1.92 per share, resulting in a dividend yield of 6.33% and a payout ratio of 79.0%. Chiron has paid dividends for 13 consecutive years, though its 5-year annualized dividend growth declined 3.8%. The last ex-dividend date is November 20, 2026.
What analysts expect
Wall Street coverage on Chiron includes 3 Strong Buy, 2 Buy, and 6 Hold ratings, with no Sell recommendations. The mean price target of $38.56 implies upside of 27.1% over the last close of $30.34. For the fiscal year ending December 31, 2026, analysts estimate revenue of $154.4M and EPS of $3.22. Chiron exceeded EPS estimates in 1 of the last 4 quarters, and its next earnings release is scheduled for November 3, 2026.
Key risks and what to watch
- Net debt of $626.3M against $10.7M in cash presents balance sheet and refinancing risks.
- For next fiscal year, analysts expect EPS to decline to -$3.18, representing a projected drop of -540.8%.
- Dilution has been substantial, with the company's share count increasing 414.4% over a 5-year period.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this XRN AI stock analysis
This page is an AI-written research summary of Chiron Real Estate Inc. (XRN). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: XRN income statement, XRN balance sheet, XRN key metrics, XRN analyst forecast, XRN chart. See the XRN stock overview for the latest quote and news.
XRN AI stock analysis FAQ
What dividend does Chiron Real Estate Inc. pay?
Chiron distributes a monthly dividend of $1.92 per share annualized, which equates to a forward yield of 6.33% and a payout ratio of 79.0%.
What is Chiron's current debt position?
As of June 30, 2026, Chiron had $636.9M in total debt and $10.7M in cash and short-term investments, resulting in net debt of $626.3M and a debt-to-equity ratio of 0.97.
What is the consensus analyst outlook on XRN stock?
Analysts maintain a mean price target of $38.56, representing a 27.1% premium to the last closing price of $30.34, with 5 Buy or Strong Buy ratings and 6 Hold ratings.
When is Chiron's next earnings report date?
Chiron is scheduled to announce its next earnings report on November 3, 2026.